TuHURA Biosciences
HURA
89 hedge funds and large institutions have $21M invested in TuHURA Biosciences in 2026 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 33 reducing their positions, and 21 closing their positions.
23% more capital invested
Capital invested by funds: $17M → $21M (+$3.99M)
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
1% less funds holding
Funds holding: 90 → 89 (-1)
2.74% less ownership
Funds ownership: 16.83% → 14.09% (-2.7%)
55% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$3.08M |
| 2 |
Millennium Management
New York
|
+$1.06M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$541K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$451K |
| 5 |
Jane Street
New York
|
+$382K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.1M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.17M |
| 3 |
State Street
Boston,
Massachusetts
|
-$756K |
| 4 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
-$454K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$425K |
HURA Hedge Fund Activity: Q2 2026 in Review
89 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2026, worth a combined $21M — up 23% from $17M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new HURA positions and 21 closed out — a net gain of 2 holders — while 15 added to existing stakes and 33 trimmed.
The largest buyer was Northern Trust, adding an estimated $3.08M. The largest seller was BlackRock, cutting an estimated $4.1M.
- 89 institutional investors held TuHURA Biosciences (HURA) as of Q2 2026, down from 90 in Q1 2026.
- Funds reported $21M of TuHURA Biosciences stock for Q2 2026, up 23% quarter-over-quarter.
- 23 funds opened new TuHURA Biosciences positions in Q2 2026 and 21 closed out, a net change of +2 holders.
- The largest TuHURA Biosciences buyer in Q2 2026 was Northern Trust, an estimated $3.08M added.
- The largest TuHURA Biosciences seller in Q2 2026 was BlackRock, an estimated $4.1M sold.
Based on aggregated 13F filings for Q2 2026.